Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.

Southeastern Pennsylvania Transportation Authority v. Volgenau

Court of Chancery of Delaware

August 5, 2013

SOUTHEASTERN PENNSYLVANIA TRANSPORTATION AUTHORITY, individually, and on behalf of all those similarly situated, Plaintiff,
v.
ERNST VOLGENAU, JOHN W. BARTER, LARRY R. ELLIS, MILES R. GILBURNE, W. ROBERT GRAFTON, WILLIAM T. KEEVAN, MICHAEL R. KLEIN, STANTON D. SLOANE, GAIL R. WILENSKY, SRA INTERNATIONAL, INC., PROVIDENCE EQUITY PARTNERS LLC, PROVIDENCE EQUITY PARTNERS VI L.P., PROVIDENCE EQUITY PARTNERS VI-A L.P., STERLING PARENT INC., STERLING MERGER INC. and STERLING HOLDCO INC., Defendants.

Date Submitted: April 4, 2013

Pamela S. Tikellis, Esquire, Robert J. Kriner, Jr., Esquire, A. Zachary Naylor, Esquire, Tiffany J. Cramer, Esquire, and Vera V. Gerrity, Esquire of Chimicles & Tikellis LLP, Wilmington, Delaware, Attorneys for Plaintiff.

David J. Teklits, Esquire and Kevin M. Coen, Esquire of Morris, Nichols, Arsht & Tunnell LLP, Wilmington, Delaware, and John C. Millian, Esquire, Justin A. Torres, Esquire, and Eric C. Schmale, Esquire of Gibson Dunn & Crutcher LLP, Washington, D.C., Attorneys for Defendant Ernst Volgenau.

Brian C. Ralston, Esquire and Justin Morse, Esquire of Potter Anderson & Corroon LLP, Wilmington, Delaware, and James P. Gillespie, P.C., Robert B. Gilmore, Esquire and Dana E. Hill, Esquire of Kirkland & Ellis LLP, Washington, D.C., Attorneys for Defendants SRA International, Inc., John W. Barter, Larry R. Ellis, Miles R. Gilburne, W. Robert Grafton, William T. Keevan, Michael R. Klein, Stanton D. Sloane, and Gail R. Wilensky.

Raymond J. DiCamillo, Esquire and Susan M. Hannigan, Esquire of Richards, Layton & Finger, P.A., Wilmington, Delaware, and Maeve O'Connor, Esquire, Elliot Greenfield, Esquire, and Michael T. Leigh, Esquire of Debevoise & Plimpton LLP, New York, New York, Attorneys for Defendants Providence Equity Partners LLC, Providence Equity Partners VI L.P., Providence Equity Partners VIA L.P., Sterling Parent Inc., Sterling Merger Inc., and Sterling Holdco Inc.

MEMORANDUM OPINION

NOBLE, Vice Chancellor

This case arises from the merger between a private equity sponsor and a former Delaware corporation. As part of the transaction, the controlling stockholder received a minority interest in the merged entity, a non-recourse note, certain authority in the private entity, and, in exchange for fifty-nine percent of his shares, $31.25 per share in cash. Minority stockholders received $31.25 per share in cash. A former minority stockholder has brought fiduciary duty claims against the former directors of the acquired company relating to their conduct in approving the merger and an aiding and abetting claim against the buyer (collectively, the "Defendants"). In addition to alleging that the controlling stockholder engaged in self-dealing, the former stockholder alleges that the merger was consummated at an unfair price, through an inadequate process, and in violation of the company's charter. The Defendants have moved for summary judgment.

At the center of the Defendants' motion is whether robust procedural protections were used that entitle the merger to review under the deferential business judgment rule instead of the exacting entire fairness standard. A transaction involving a third party and a company with a controller stockholder is entitled to review under the business judgment rule if the transaction is (1)recommended by a disinterested and independent special committee and (2)approved by stockholders in a non-waivable vote of the majority of all the minority stockholders.

Because of the procedural protections that were used, the Court reviews the merger under the business judgment rule. The Court concludes that there is no dispute of material fact that the merger-related decisions of the directors of the former company were attributable to a rational business purpose and that the buyer was an arms' length bidder. The former shareholder asserts a duty of loyalty claim against the directors for consciously disregarding a provision in the company's charter requiring that the controlling stockholder receive "equal" consideration as all other stockholders in a merger. Because there is no dispute of material fact that the former directors did not act in bad faith, and because the Defendants are entitled to judgment on all claims asserted against them, the Court grants the Defendants' motions for summary judgment on all counts.

The Plaintiff, Southeastern Pennsylvania Transportation Authority ("SEPTA" or the "Plaintiff"), brings claims arising from the buy-out (the "Merger") of Defendant SRA International, Inc. ("SRA" or the "Company") by Defendants Providence Equity Partners LLC ("Providence") and its related entities.[1] SEPTA asserts fiduciary duty claims against the former directors of SRA (the "SRA Directors" or the "Board"), who include Ernst Volgenau ("Volgenau"), the former controlling stockholder of SRA, and Stanton D. Sloane ("Sloane"), the former chief executive officer ("CEO") of SRA, relating to their conduct in connection with the Merger.[2] SEPTA also asserts that Providence aided and abetted the SRA Directors' breach of their fiduciary duties.

I. BACKGROUND

A. An Overview of the Claims

SEPTA has asserted four claims in its Verified Second Amended Class Action Complaint (the "Complaint").

• Count I asserts a breach of the duty of loyalty and duty of care against the SRA Directors (including Volgenau) for approving the merger agreement, disclosing misleading or incomplete information, and failing to disclose material information.
• Count II asserts a breach of the duty of loyalty and duty of care against Volgenau and Sloane. Volgenau is accused of "planning, structuring and timing the [Merger] to benefit himself . . . at the unfair expense of the stockholders and in violation of the equal treatment provision of the Certificate of Incorporation."[3] Sloane is alleged to have "encourage[d] and facilitate[d] the [Merger]" and Volgenau's self dealing conduct.[4]
• Count III asserts that Providence aided and abetted the SRA Directors' breach of fiduciary duties in Counts I and II.[5]
• Count IV asserts that the SRA Directors breached their fiduciary duties by approving the Merger in violation of SRA's certificate of incorporation (the "certificate" or "charter").

B. Procedural History

Following the announcement of the Merger, SEPTA filed its original complaint on April 7, 2011. Thereafter, it filed a Motion for Preliminary Injunctive Relief based on unresolved disclosure claims, but withdrew its motion when the Defendants made supplemental disclosures. On June 21, 2011, the Plaintiff filed its most recent Complaint. The SRA Defendants filed a Motion for Judgment on the Pleadings as to Count IV, which the Court granted in part and denied in part.[6] The Court held that "SEPTA's claim that the Merger is invalid fails as a matter of law" under 8 Del. C. § 124. However, the Court denied the Defendants' motion to dismiss "SEPTA's claim that [the SRA Directors'] breached their fiduciary duties by approving a transaction that violated SRA's certificate of incorporation."[7]

C. Parties

SEPTA was a stockholder of SRA at the time of the Merger. Volgenau founded SRA in 1978.[8] SRA is a leading provider of technology solutions and professional services, primarily to the federal government.[9] SRA serves customers in four markets: national security, civil government, health, and intelligence and space. At the time of the Merger, Sloane was SRA's CEO. The Board consisted of Volgenau, Sloane, Klein, Gilburne, Grafton, Barter, Ellis, Keevan, and Wilensky.

Providence is a private equity firm specializing in equity investments in media, communications, information services, and education.[10]

D. History of SRA

Volgenau has been SRA's controlling stockholder from its inception in 1978. In 2002, the Company made an initial public offering. As a public company, SRA had two classes of common stock: Class A and Class B. The only difference between the two classes of stock was that a holder of Class A stock was entitled to one vote per share, while a holder of Class B stock was entitled to ten votes per share.[11] Despite owning only 21.8 percent of the outstanding equity of the Company, Volgenau retained control of SRA through his ownership of Class B common stock, which enabled him to control approximately 71.8 percent of the voting power.[12]

Under the terms of SRA's certificate, Volgenau could convert—at any time—each share of his Class B common stock to one share of Class A common stock. Each Class B share was also subject to an automatic conversion at the same one-to-one ratio upon the occurrence of certain events, such as the death of the holder, loss of competency, and if the holder became eighty years old and was no longer affiliated with the Company.[13] The certificate also required that the holders of Class A and Class B common stock be treated equally in the event of a merger.[14]As Volgenau testified in his deposition, the "primary objective in having Class B stock was to prevent harmful takeovers of the company, not to enrich the Class B shareholders."[15]

SEPTA asserts that Volgenau dominated and controlled SRA.[16] There is no doubt that Volgenau, even after stepping down as SRA's CEO in 2002, exercised considerable influence over the operations of the Company in his capacities as Chairman of the Board and controlling stockholder.[17] Volgenau actively participated in the selection of his replacement, Renato DiPentima ("DiPentima"), and DePentima's successor, Sloane. As the Company struggled under Sloane, he regularly conferred with Sloane on all "major decisions."[18] Perhaps neither of these actions is unusual for a Chairman. But, as a controlling stockholder, Volgenau's influence was more pervasive. When Sloane terminated the employment of a valuable executive, Volgenau arranged to keep the former employee engaged as a consultant to SRA.[19] As SRA struggled under Sloane, SRA began considering possible strategic alternatives, including a sale of the Company. During that time, Volgenau was actively involved in the decision to pursue a strategic transaction and in ensuring that the Company's ethics of honesty and service would be preserved.[20]

SEPTA attempts to cast a negative light on Volgenau's insistence on preserving the Company's values and culture, asserting that it had a "negative economic impact."[21] Whether that is true or not, Volgenau testified that "many people believe that honesty and service increased the market value of . . . SRA."[22] At least initially, Volgenau's views affected his willingness to consider a sale of the Company to a strategic acquirer. In his book, Volgenau candidly admits that he had a negative disposition to that type of buyer.

Virtually every year since our founding I had been approached by a CEO in a company that wanted to buy SRA. In each case I declined, explaining that we were on a special mission to create one of the world's great companies—a business and ethical success. . . . I don't think any of those CEOs and companies were unethical, but they could not compare with SRA. I began to refer to them privately . . . as "sausage factories" that would grind up SRA and homogenize us into their system. Our name, values and culture would be lost forever. Many of those companies were quite successful, but I did not want SRA to become an Oscar Meyer [sic] wiener.[23]

The record reflects that the idea to sell SRA was never seriously considered until a few years after the Company had begun to experience various problems. Since 2008, SRA had been experiencing declining growth rates, lower profit margins, and poorly performing acquisitions.[24] As the Company's performance continued to falter in 2010, [25] Volgenau became interested in the prospect of a leveraged buy-out ("LBO"), which would, in theory, provide stockholders with a substantial premium to SRA's current stock price and afford Volgenau a better opportunity to preserve the Company's values and culture. But, as Volgenau acknowledged in his book, once he (and the Board) made the decision to sell SRA, the eventual acquirer might very well be a strategic competitor.[26]

E. The Early Meetings with Providence

SEPTA asserts that Providence aided and abetted the SRA Directors' breach of fiduciary duty. In support of this theory, SEPTA points to Providence's retention of DiPentima, a former CEO of SRA, Volgenau's friend, and a paid consultant to SRA, [27] to exploit Volgenau's trust in DiPentima to effectuate a deal. Similarly, the Plaintiff contends that Ted Legasey ("Legasey"), also a former senior SRA executive and friend of Volgenau, was recruited to persuade Volgenau to sell the Company to Providence.[28] In the spring of 2010, after an initial meeting between DiPentima and Volgenau, in which DiPentima raised the idea of an LBO, [29] Julie Richardson, the CEO of Providence, and other Providence employees began meeting with Volgenau and the senior management of SRA to discuss a possible buyout. These meetings involved preliminary discussions about the possibility of Volgenau's participating in the acquired company, indicative price points, and the importance of maintaining the value and culture of SRA.[30] During this time Volgenau inquired about Providence's ability to obtain the necessary financing and whether a go-shop would disrupt the sale to Providence if an agreement could be reached.[31] Providence provided research to Volgenau showing that it was highly unlikely that a topping bidder would emerge during the go-shop period.[32] SRA shared proprietary information with Providence pursuant to a confidentiality agreement and SRA management developed various LBO scenarios. As discussions ensued, Volgenau was not only amenable to a transaction with Providence, but he also seemed to have significant interest in completing a deal with it.

F. The Study Team

At the same time as Volgenau was in discussions with Providence, on May 3, 2010, the Board formed a "study team" to assess the strategic alternatives for SRA. The study team included Volgenau, Klein, Gilburne, and Grafton. Notably, Klein encouraged Volgenau to exploit his particular interests as a controlling stockholder.

You are 77 years old. If you die or become incapacitated, your estate will no longer have the Class B (ten for one) voting shares, and the company's disposal will be unpredictable. Wouldn't you rather determine its future now, while you are in good health?[33]

The study team hired CitiGroup to provide advice on strategic alternatives; it opined that a significant acquisition would best maximize the Company's long- term value because it would lead to "more technology and higher profits."[34]

Consistent with that advice, SRA made a serious attempt to acquire Lockheed Martin's Enterprise Integration Group ("EIG") during the summer and fall of 2010. Although Volgenau supported SRA's attempted acquisition of EIG, he also had a desire to continue talks with Providence, even though the acquisition would either postpone or preclude any deal with Providence.[35] Legasey, on behalf of Providence, tried to persuade Volgenau not to pursue the EIG acquisition and warned that Providence would no longer be interested in acquiring SRA.[36]Nonetheless, SRA proceeded with its bid, but ultimately lost out to Veritas Capital ("Veritas"), which purchased the EIG unit for $815 million.

G. The Formation of the Special Committee and Other Indications of Interest

Following the failed EIG bid, Volgenau and the Board turned its attention again to Providence. During an October 27, 2010, study team meeting, Volgenau indicated that Providence was the only potential bidder that had ever interested him and that it was committed to maintain the Company's values and culture.[37] With Volgenau's tacit endorsement of Providence, Klein suggested that the Board form an independent special committee, which it did the following day (the "Special Committee").[38] The Special Committee, which was comprised of Klein, as chair, along with Gilburne, Grafton, Barter, and Ellis, [39] was charged with evaluating, soliciting third-party interest in, and negotiating potential strategic transactions.[40]The Special Committee's mandate also included an express authorization to hire its own advisors.[41]

The Special Committee hired a financial advisor, Houlihan Lokey Capital, Inc. ("Houlihan"), and legal counsel, Kirkland & Ellis LLP ("Kirkland"), to assist it in its evaluation of potential strategic transactions. SEPTA asserts that both Houlihan and Kirkland were hired because of their prior professional and personal relationships with Klein. According to Klein, they were selected because they had no prior experience with SRA and they were well qualified.[42] Volgenau was also instructed that he should not have "any further discussions with Providence [or any other bidder] except as may be approved and coordinated by the Committee . . . ."[43]

On November 22, 2010, Houlihan and Klein met with representatives from Providence. During the meeting Klein informed Providence that SRA had decided not to undertake a formal sale process and that Providence's initial $28 per share expression of interest was insufficient to start formal discussions. On behalf of the Special Committee, Klein also rejected Providence's request for exclusivity, but permitted it to conduct further due diligence.[44]

As the Special Committee awaited Providence's formal bid, on December 1, 2010, Serco, a strategic competitor, proposed a transaction at a higher price range ($29-$31 per share) than Providence's initial indication of interest. In an email dated December 9, 2010, Klein advised Providence of the superior offer, but noted that "Ernst has fended off numerous interested parties over the past years and had every intention to continue to do that while we await your proposal."[45] Klein testified that his email was intended to elicit a higher offer from Providence that would start the process at $30 per share or more.[46] However, on December 29, 2010, Providence submitted a bid of $27.25 per share.[47]

Not surprisingly, the Special Committee viewed Providence's preliminary expression of interest as insufficient to start the negotiation process with Providence.[48] Consequently, the Special Committee determined that "it was appropriate to explore and assess additional third-party interest . . . in a potential strategic transaction with the Company."[49] Accordingly, in early January 2011, the Special Committee decided to solicit five financial buyers: The Carlyle Group ("Carlyle"), TPG Capital ("TPG"), Kohlberg Kravis & Roberts (KKR"), Veritas and Bain Capital ("Bain"), as well as continue discussions with Serco.[50] A sixth financial sponsor—Hellman & Friedman—was later added to the mix. Although the Board was generally aware that strategic acquirers in theory had the potential to pay more for SRA, [51] Grafton testified that the reason that the Special Committee declined initially to solicit other strategic acquirers was in order to safeguard confidential and proprietary information and avoid "leaks into the marketplace."[52]

By mid-January, however, the markets began to speculate that SRA had received acquisition proposals. After Sloane cancelled his appearance at a January 6 investor conference, SRA's stock price rose 19 percent in one week based on rumors that SRA was for sale.[53] Moreover, word leaked erroneously that Serco had submitted, and SRA had rejected, a $2 billion offer to buy SRA.[54] As a result of the ensuing publicity, much of which was negative, [55] Serco withdrew its preliminary offer and terminated discussions with SRA.

On January 25, 2011, SRA confirmed publicly that it had received "a series of inquiries regarding the company's willingness to consider offers" and therefore, SRA had retained Houlihan to provide advice. Although the press release cautioned that "the retention of advisors does not reflect a decision that the company is or should be for sale, " by then it was clear that SRA was entertaining acquisition offers.

In light of the newfound publicity and the ensuing expressions of interest, the Special Committee sought to open up the bidding process to other strategic sponsors to extract the maximum possible value for SRA.[56] To his credit, Volgenau consented.[57] To address Volgenau's concerns, however, the Special Committee established a bifurcated process in which it would exclusively address issues of price and certainty while Volgenau would meet with strategic acquirers to discuss his "humanistic concerns."[58] Thus, in February and early March, Volgenau met alone with strategic and financial sponsors to learn more about them and to discuss his desire that "SRA's name, values and culture be preserved."[59]

On February 4, 2011, Houlihan contacted three other strategic bidders: The Boeing Company ("Boeing"), CGI, and Hewlett Packard ("HP"), and one additional financial buyer: GTCR LLC ("GTCR").[60] Another strategic bidder— L-3 Communications Holdings, Inc. ("L-3")—also contacted Houlihan to express interest in a potential transaction.[61] During the due diligence process, strategic and financial sponsors signed confidentiality agreements and conducted due diligence on SRA—which included access to a confidential data room and meetings with the senior management of SRA.[62] Ultimately, for various reasons, all but two of the potential bidders chose either not to join the sale process or to submit a formal offer for the Company.[63]

H. The Multi-Round Bidding Contest Between Veritas & Providence

With all of the remaining suitors having dropped out of the bidding process, Veritas and Providence became engaged in a multi-round bidding contest.[64] On March 18, 2011, Providence submitted an offer to purchase SRA for $30 per share. Two days later, Veritas made a written offer for the same amount, but conditioned it on Volgenau's increasing his rollover amount from $100 million to $150 million. Volgenau agreed to do so. He also agreed to the same rollover amount for Providence, if it desired.[65]

By March 30, the $30 per share deadlock was broken when Veritas improved its offer to $31 per share and Providence increased its offer to $30.50. However, on the evening of March 30, 2011, Providence made two new proposals to increase its bid to $31 per share or higher. First, Providence made an offer "consisting of $30.50 plus a contingent amount equal to the proceeds (if any) received from the sales of two of the Company's subsidiaries, [Era Systems LLC ("Era")] and [Global Clinical Development ("GCD")], [both of which were] currently being marketed."[66] Second and alternatively, Providence offered to increase the purchase price to $31 per share if Volgenau would "agree as part of his [$150 million] rollover commitment to provide a $30 million non-recourse loan to Providence, which loan would be repaid" only if the Company realized sufficient proceeds from the sale of the two subsidiaries being marketed.[67]Importantly, with respect to the second proposal, the Special Committee concluded that Volgenau would not be receiving "any additional economic benefit under the loan if the proceeds of such subsidiary sales were to exceed $30 million."[68]Volgenau consented to the second proposal even though, in Volgenau's words, "it was a rotten deal for me" because "there was no upside and all downside, and [Era and GCD] we knew were risky."[69]

On the same day and shortly after Providence's latest proposals were discussed by the Special Committee, Veritas increased its bid to $31.25 per share and requested exclusivity in negotiations until the next business day.[70] During the meeting to discuss Veritas' latest proposal, the Special Committee voted to negotiate exclusively with Veritas until 3:00 p.m. the following day. Efforts to finalize the transaction documents stalled, however, as the advisors to the Special Committee—specifically, Kirkland—identified a potential issue related to Veritas' contractual ability to finance the transaction and to obtain the necessary partnership approvals.[71] As the exclusivity period ended, Providence raised its bid to $31.25 per share. With both bidders deadlocked again, the Special Committee requested each bidder to submit its best and final offer by 5:00 p.m.[72] Apparently frustrated by the Special Committee's conduct in dragging the process along, Veritas instead withdrew its $31.25 bid, leaving Providence, which declined to make a higher offer, as the only remaining bidder.

During the March 31, 2011, Board meeting, the Special Committee unanimously recommended to the Board that SRA accept Providence's offer. Houlihan opined that the $31.25 per share offer was fair. Kirkland summarized the terms of the proposed transaction, which included a 30-day go-shop provision, a $28.2 million breakup fee during the go-shop (i.e., 1.5 percent of the deal value), a $47 million termination fee after the go-shop (i.e., 2.5 percent of the purchase price), and a reverse breakup fee of $112.9 million. The Merger was also subject to a majority of the minority vote that was not waivable by the Special Committee. Except for Volgenau who abstained, the Board voted unanimously to approve the merger agreement and to recommend the Merger to SRA's stockholders.

During the go-shop, Houlihan solicited 50 potential bidders, including 29 strategic sponsors and 21 financial buyers.[73] No bidders emerged with an additional offer. The definitive proxy statement was mailed to stockholders on June 15, 2011. SRA made supplemental disclosures after the Plaintiff claimed that the proxy had omitted material information relating to Volgenau's meetings with four potential buyers and Houlihan's relationship with Providence. On July 15, 2011, SRA's minority stockholders approved the merger with 81.3 percent of the total outstanding minority shares (99.7 percent of the total minority voting shares) voting in favor of the Merger.[74] The Merger, valued at $1.88 billion, closed on July 20, 2011. SRA stockholders received $31.25 per share in cash, which represented a 52.8 percent premium over SRA's stock price on December 31, 2010.[75]

II. CONTENTIONS

The Defendants contend that there is no triable issue of material fact about whether the business judgment rule applies because robust procedural protections were used to effectuate the Merger. Even if the business judgment rule does not apply, the Defendants assert that they are still entitled to judgment under the entire fairness standard. In response, SEPTA contends that there are disputes of material fact precluding (a) the application of the business judgment rule and (b) the Court from granting the Defendants' summary judgment motions. First, SEPTA asserts that Volgenau stood on both sides of the transaction. It also attacks the independence or disinterestedness of certain Special Committee members. SEPTA contends that Klein was self-interested because he harbored a secret desire to receive a significant bonus in return for orchestrating a transaction with Volgenau's allegedly preferred bidder—Providence. SEPTA further maintains that Volgenau, with the help of Sloane, dominated the Special Committee process through his initial discussions with Providence and by having unauthorized contact with bidders after the Special Committee was formed. In addition, SEPTA argues that the Special Committee advisors were self-interested and intentionally sought to derail Veritas' bid. It further asserts that the stockholders were not fully informed of all material facts when they overwhelmingly approved the Merger. Second, the Plaintiff contends, and offers expert testimony in support, that the Merger price was unfair. The Defendants respond by arguing that the facts proffered by SEPTA are immaterial and the evidence in the record shows that the Merger price was fair. The Defendants, in addition, contend that the Court need not resolve the differing opinions of the experts because the fairness of the Merger price was confirmed by a robust and lengthy sale process and the Board reasonably relied upon Houlihan's fairness opinion.

Count III alleges that Providence aided and abetted the SRA Directors' breach of their fiduciary duties. The Plaintiff asserts that Providence knowingly participated in the SRA Directors' breach of their fiduciary duties because of its hiring of former SRA employees and its alleged "partnership" with Volgenau. In response, the Defendants contend that there is no dispute of material fact that the SRA Directors breached their fiduciary duties or that Providence knowingly participated in such a breach. Count IV asserts that the SRA Directors breached their duty of loyalty by approving the Merger in violation of SRA's certificate.[76]SEPTA contends that Volgenau received greater consideration in the Merger than did the minority stockholders and that the Board did not even attempt to adhere to the charter's equal treatment provision. The Defendants have countered by asserting that the record indisputably shows that the SRA Directors did not knowingly disregard the equal treatment provision or believe that Volgenau was receiving greater consideration in the Merger.

III. ANALYSIS

A. The Summary Judgment Standard

Summary judgment is appropriate when the record shows "that there is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law."[77] "[E]ven where 'colorable . . . or [in]significantly probative [evidence]' is present in the record, [summary judgment is appropriately granted] if no reasonable trier of fact could find for the plaintiff on that evidence."[78] The Court views the evidence in the light most favorable to the nonmoving party and assumes the truth of uncontroverted facts set forth in the record.[79] "When the moving party shows that no genuine issue of material fact exists, 'the burden shifts to the nonmoving party to substantiate its adverse claim by showing that there are material issues of fact in dispute.'"[80] If the burden shifts to the nonmoving party, summary judgment is appropriate "where that party fails to make a sufficient showing on any essential element of its case."[81]

B. A Note on In re MFW Shareholders Litigation

As an initial matter, the Court's recent decision in In re MFW Shareholders Litigation ("MFW")[82] illuminates many of the procedural protections at issue in this case. For the first time, the Court addressed the question whether, and under what conditions, a merger between a controlling stockholder and its subsidiary could be reviewed under the business judgment rule, as opposed to the entire fairness standard. The Court held that the business judgment rule could apply if all of the following conditions were satisfied: (1) the controlling stockholder at the outset conditions the transaction on the approval of both a special committee and a non-waivable vote of a majority of the minority investors; (2) the special committee was independent, (3) fully empowered to negotiate the transaction, or to say no definitively, and to select its own advisors, and (4) satisfied its requisite duty of care; and (5) the stockholders were fully informed and uncoerced.[83]

In concluding that this structure would benefit minority stockholders, the Court explained:

[S]tockholders get the benefits of independent, empowered negotiating agents to bargain for the best price and say no if the agents believe the deal is not advisable for any proper reason, plus the critical ability to determine for themselves whether to accept any deal that their negotiating agents recommend to them.[84]

The Court further reasoned that, because these procedural protections had the effect of replicating an arms' length transaction, they had a "cleansing" effect on the transaction that justified judicial review under the deferential business judgment rule.[85]

Unlike MFW, which involved a controlling stockholder on both sides of the transaction, this case involves a merger between a third-party and a company with a controlling stockholder. Despite SEPTA's attempt to show otherwise, Volgenau is not a buyer in this transaction. As a seller, his interest is generally aligned with that of minority stockholders to the extent that he receives equal consideration for his shares. But as this Court has observed before, a controlling stockholder may, even in this context, inappropriately influence the outcome of the sale process:

[I]t is . . . true that [a controlling stockholder] and the minority stockholders [are] in a sense competing for portions of the consideration [that the third-party is] willing to pay to acquire [the company] and that [the controlling stockholder] . . . could effectively veto any transaction. In such a case it is paramount . . . that there be robust procedural protections in place to ensure that the minority stockholders have sufficient bargaining power and the ability to make an informed choice of whether to accept the third-party's offer for their shares.[86]

Hammons sets forth the procedural protections necessary for a third-party transaction involving a controlling shareholder to qualify for review under the business judgment rule: (1) the transaction must be recommended by a disinterested and independent special committee, (2) which has "sufficient authority and opportunity to bargain on behalf of minority stockholders, " including the "ability to hire independent legal and financial advisors[;]" (3) the transaction must be approved by stockholders in a non-waivable majority of the minority vote; and (4) the stockholders must be fully informed and free of any coercion.[87]

C. The Standard of Review: Entire Fairness or Business Judgment?

As a threshold issue, the parties dispute whether the Court should review the Merger under the entire fairness standard or the business judgment standard. SEPTA contends that entire fairness is warranted because Volgenau stood on both sides of the transaction. In response, the Defendants urge the Court to apply the business judgment rule because the transaction was subject to robust procedural protections, namely, a non-waivable majority of the minority vote and a disinterested and independent Special Committee.

1. Did Volgenau Stand on Both Sides of the Merger?

The Plaintiff's assertion that Volgenau stood on both sides of the Merger is based both on Volgenau's desire to preserve the culture and values of SRA and his rollover of equity into the merged entity. According to the Plaintiff:

Volgenau and his interest were the reasons the sale process started. . . By engaging as he did with Providence and then foisting it upon the Board as the only buyer that had ever interested him, he placed himself knowingly and willfully in the shoes of a buyer in this Merger.[88]

SEPTA further contends that Volgenau had a "heavy influence" on the sale process through his selection of the Special Committee members, by steering the process away from strategic sponsors, and by having contact with Providence, despite explicit instructions not to do so.[89] Volgenau's relationship to Providence was underscored, the Plaintiff asserts, by the fact that Providence, in a presentation to lenders, referred to Volgenau as its partner and highlighted its special relationship with him.[90]

The contention that Volgenau stood on both sides of the transaction is not supported by the factual record or Delaware law. First, the record discloses no prior affiliation between Volgenau and Providence. In fact, they had no relationship before the spring of 2010 when Volgenau and representatives of Providence first met to discuss a potential transaction.[91] Moreover, Volgenau's conversations with Providence in which a leveraged buyout was preliminarily discussed did not somehow magically transform Volgenau into an affiliate of Providence.

Second, under Delaware law, "[w]hen a corporation with a controlling stockholder merges with an unaffiliated company, the minority stockholders of the controlled corporation are cashed-out, and the controlling stockholder receives a minority interest in the surviving company, the controlling stockholder does not 'stand on both sides' of the merger."[92] The Hammons court rejected a similar contention that a controlling stockholder's retention of an equity interest and other benefits created a "joint venture of some sort" or a "recapitalization."[93] As in Hammons, where an unrelated entity made an offer to the Special Committee representing minority stockholders, [94] Providence, an entity unaffiliated with SRA, made offers to, and negotiated with, SRA through a disinterested and independent Special Committee that represented the interests of the minority stockholders. Volgenau, who had the right to vote or not to vote his shares, did not become a buyer in the Merger because he engaged in separate discussions with Providence regarding his humanistic concerns.

Third, the Plaintiff's assertion that Volgenau foisted upon the Special Committee and the Board his preferred and only buyer, and then dominated the Board to effectuate that transaction, is belied by the record. Importantly, the Plaintiff has failed to dispute materially that the Special Committee executed a robust process in which all interested bidders were afforded an equal opportunity to buy SRA.

Accordingly, because there is no genuine issue of material fact as to whether Volgenau did not stand on both sides of the transaction, the Merger will be reviewed under the business judgment standard to determine if it satisfies the test set forth in Hammons.

2. Was the Special Committee Disinterested and Independent?

The Plaintiff attempts to discount the independence and disinterestedness of the members of the Special Committee by asserting that (a) Klein had a secret motivation to deliver a deal with Providence to Volgenau—who was self-interested in the Merger; and (b) the Special Committee was dominated by Volgenau and Klein. Each of these contentions is addressed below.

The business judgment rule is a "presumption that in making a business decision, the directors of a corporation act on an informed basis [i.e., with due care], in good faith and in the honest belief that the action taken was in the best interests of the company [i.e., loyally]."[95] Accordingly, there is a presumption that directors are independent under Delaware law.[96] To rebut the business judgment rule on grounds of self-interest, the plaintiff must establish, first, that a director had a "material self-interest in the challenged transaction. Evidence of mere self-interest is not enough. Rather, there must be evidence of a substantial self-interest suggesting disloyalty . . . ."[97] Thus, directors may not "expect to derive any personal financial benefit from [the transaction] in the sense of self-dealing, as opposed to a benefit which devolves upon the corporation or all stockholders generally."[98]

Second, as to the self-interested directors, the Plaintiff must show that they:

a) constituted a majority of the board; b) controlled and dominated the board as a whole; or c) i) failed to disclose their interests in the transaction to the board; ii) and a reasonable board member would have regarded the existence of their material interests as a significant fact in the evaluation of the proposed transaction.[99]

Thus, the "mere presence of a conflicted director or an act of disloyalty by a director, does not deprive the board of the business judgment rule's presumption of loyalty."[100] Independence "means that a director's decision is based on the corporate merits of the subject before the board rather than extraneous considerations or influences."[101] To rebut the presumption of independence, a plaintiff must demonstrate that the directors are "beholden" to the self-interested parties or "so under their influence that their discretion would be sterilized."[102]

(a) Was Klein Self-interested in the Merger?

First, the Plaintiff's contention that Klein had a secret interest in pleasing Volgenau is based in part on his undisclosed expectation that he would receive a significant bonus for his work with the Special Committee. On February 3, 2011, the Board set the Special Committee compensation at $75, 000 for Klein and $37, 000 for the other members.[103] At Volgenau's urging, when the Board approved the merger agreement during a March 31, 2011, Board meeting, it again changed the Special Committee compensation to $75, 000 for each member and an additional $150, 000 for Klein. However, Klein declined the additional compensation, explaining later that he did so because it was "premature."[104] As a result, the Board elected to make a charitable contribution of $150, 000 to two charitable organizations supported by Klein.[105]

On June 8, 2011, however, Klein sent Volgenau a memorandum in which he expressed disappointment over the meager compensation offered to him for his eight months of work directing the sale process and in light of the nearly $30 million in fees and expenses paid to outside advisors for their help in effectuating the Merger.[106] Klein wrote that, based on his previous experience as the chair of a special committee at a different company, a more reasonable amount of compensation would have been at least $1.3 million, payable to two charities with which Klein is affiliated.[107]

SEPTA contends that Klein, in addition to enriching himself, was likewise interested in rewarding his professional associates. It points out that Klein had a close professional relationship with Kirkland's lead transactional attorney— George Stamas ("Stamas"). Both Klein and Stamas had been partners at the same law firm and both were then serving as directors on the Shakespeare Theatre Company board.[108] As the chair of the Special Committee, Klein negotiated with Kirkland for a ten percent discount in fees in exchange for a "significant" bonus if a "terrific economic outcome" was achieved.[109] After the Merger was completed, Klein then attempted to secure a $2 million bonus for Kirkland.[110] Due to vigorous opposition from Providence, the Special Committee eventually agreed to reduce Kirkland's bonus to $1 million.[111] Finally, along with Klein and Stamas, Houlihan's lead banker was also a donor and board member of the Shakespeare Theatre Company.[112] SEPTA similarly contends that Houlihan was incentivized to steer the process to a completed transaction, regardless of the merits of the deal, because the majority of its compensation was contingent upon SRA's entering into a deal.[113]

Perhaps Klein had an interest in pleasing Volgenau, as one friend might have for another, but Klein was clearly independent of Volgenau. There is no evidence that Klein was beholden to, or controlled by, Volgenau or that they had any personal or business relationships outside of, or prior to, their interaction on the SRA Board. That Klein encouraged Volgenau to determine the future of SRA while he remained in a position to do so may be peculiar, but it does not suggest that Klein was dominated by Volgenau.[114] Moreover, although Klein informed Providence of Serco's superior offer, the reason that Klein did so is disputed. The Plaintiff, of course, speculates that Klein was somehow helping Providence by tipping it off to Serco's offer. But Klein's email to Providence does not show that he was favoring Providence. Rather, the evidence shows that Klein, on behalf of the Special Committee, intended to elicit a higher offer from Providence.[115]

More troubling is Klein's request to Volgenau for additional compensation.[116] Although the request occurred after the merger agreement had been signed, Klein's email revealed that he had an expectation, based on previous experience, that he should or would receive substantial compensation contingent upon a completed merger and a favorable outcome.[117] Because of his experience, it is likely that Klein anticipated a possible bonus well before the merger agreement was signed. Yet Klein never disclosed that expectation to the Board until just a few days before the proxy was sent to stockholders.

The Defendants emphasize that Klein's request was rebuffed and the actual compensation he received was customary and fully disclosed. Directors serving on a special committee are entitled to reasonable compensation for their efforts. As a general rule, a director's financial interest in his or her fees is not disqualifying unless those fees are substantial.[118]

Klein's subjective expectation of a possible bonus—substantially in excess of the amount originally approved or ever contemplated by the Board—raises a serious question regarding Klein's motivation for completing a deal. SEPTA cites In re Tele-Communications, Inc. Shareholders Litigation[119] for the proposition that the compensation of a special committee member that is "contingent, ambiguous, or otherwise uncertain, raises a triable issue of material fact as to what each member anticipated in the event the Special Committee approved the transaction."[120] In Goodwin, two directors' subjective expectancy of future employment after a change in control was "sufficient evidence to generate a triable issue of fact" regarding whether the potentially self-interested directors' "expectations constituted a material interest in the merger not shared by the stockholders."[121] In contrast, the Court also held that a third director's subjective expectancy in a future consulting agreement with the financial buyer did not create a triable issue of fact whether the "[director] had a material self-interest in the merger[, ]"[122] notwithstanding that the director and the buyer had negotiated over the agreement during the sale process. In so holding, the Court explained that the plaintiff had not alleged that the "potential sums [the director] would have received from the consulting agreement would have, in the context of his annual income and net worth, been of such value to have made it difficult for him to examine the merger on the basis of its merits to [the company's] stockholders alone."[123]

Klein may have had, at all times, an unremitting focus to obtain the highest reasonably attainable price. His desire for personal aggrandizement may not have affected adversely his conduct as the chair of the Special Committee. Perhaps his intention to seek a bonus formed only after he realized the significant disparity between his compensation and the compensation of the advisors to the Special Committee. Klein admittedly regarded his role in the outcome as invaluable and second in importance only to Volgenau's.[124]

But Klein may have also been influenced by other desires. If he believed that a significant bonus was likely to depend upon a completed deal, he may have been less aggressive in negotiating with Providence and Veritas.[125] It is also possible that Klein may have been subtly motivated to favor Volgenau's interest because he knew that a significant bonus was dependent upon receiving Volgenau's consent. Indeed, when Klein pressed his case for why he was deserving of a substantial reward, he specifically referred to completing a deal with the buyer that would retain SRA's name, values, and culture and "least adversely affect SRA's family of long time employees."[126]

If Klein were any other member of the Special Committee, there would be concern over whether his self-interest in the outcome affected the sale process. Although he was not a "de facto one man committee, " Klein clearly had a predominant role in the negotiations. In a merger involving a controlling stockholder, the "composition of the special committee is of central importance" because it represents the interests of the minority stockholders.[127] The independence of each member is the "sina qua non of the entire negotiation process."[128] Especially in a case where the special committee is composed of only one director, the standard of independence requires that the member, "like Caesar's wife, to be above reproach."[129] Similarly, Klein's independence and disinterestedness is of central importance to the functioning and cleansing effect of the Special Committee.

Unlike in In re Tele-Communications, Inc., where the board approved a plan in advance to "reasonably compensate the Special Committee, "[130] the Board here never approved a plan upfront to compensate the Special Committee members on a contingent basis, nor did it grant Klein's request.[131] In that respect, Klein's post-merger agreement request may have been merely wishful thinking, but that does necessarily mean that Klein's interest in the Merger was not material to him.

The subjective standard is used when determining whether a director's financial self-interest in a merger is material.[132] Ordinarily, the prospect of receiving $1.3 million would be material, [133] but Klein specifically requested that the entire bonus go to two charities with which he was affiliated. Thus, in order to find that Klein had a material self-interest in the Merger, the Court would have to conclude that, had the bonus been distributed to Klein's affiliated charities, he would have materially benefited in some way from donating the money. Although Klein serves as a board member on his affiliated charities, there is no evidence in the record that Klein would have received any backdoor remuneration, measured in dollars or accolades, for a donation made because of him.

That Klein wrote a well-thought-out memorandum to explain why he was deserving of the bonus would suggest that it was material to him. However, that is not enough to raise a triable issue of material fact or rebut the presumption that Klein is independent. The Plaintiff has failed to set forth other facts showing that the requested bonus would have been material to him. Klein's request that the bonus be paid to charity, rather than to himself, strongly suggests that the monetary payment was not material to him.[134] Perhaps Klein sought the donation to obtain accolades or enhance his prestige. That type of interest is not easily measured, and SEPTA has not proffered any facts in support of that theory. Without more, the Court declines to conclude that there is a dispute of material fact that Klein had a material self-interest in the Merger.

Equally important to that conclusion is that there is no other evidence in the record that Klein was otherwise self-interested in the Merger or favored Volgenau's alleged interest in a deal with Providence. Indeed, that both Providence and Veritas complained that the Special Committee was dragging the process along is perhaps some evidence that Klein was not less aggressive in the negotiations to ensure that a deal was completed. Moreover, Klein's memorandum suggests that he would have likely requested a bonus regardless of whether a deal was done with Providence or some other buyer.[135]

The Plaintiff has also failed to proffer evidence that Klein's interest infected the Special Committee as a whole. The Special Committee's legal and financial advisors were not tainted by their relationship with Klein or by their compensation structure.[136] They were rationally selected because of their location, competence, and lack of any prior relationship to SRA.[137] Klein's effort to compensate Kirkland for a job well done was not inconsistent with his fiduciary duties, especially because Kirkland's discretionary bonus was contemplated by the terms of Kirkland's engagement.[138] Furthermore, Kirkland's identification of a potential issue with Veritas' need to obtain partnership consents to finance its proposed merger does not imply that Kirkland or Klein was favoring Providence. Indeed, there is no evidence in the record that the Special Committee's concern (or Kirkland's concern) was pretextual. In fact, the record contains ample evidence that the Special Committee (including Klein) would have voted in favor of either Veritas or Providence given the value of the bids on the table.

In summary, the Court concludes that there is no genuine issue of material fact as to whether Klein had a material self-interest in the Merger. Furthermore, there is no triable issue of material fact that any interest of Klein did not infect the process and deliberations of the Special Committee.

(b) Did Klein or Volgenau Dominate the Special Committee?

SEPTA further asserts that the Special Committee was dominated or controlled by Klein or Volgenau. However, there is no basis in the record for either assertion. With respect to Klein, the record does not imply that Klein was a "de facto one man committee."[139] To be sure, Klein, as chair of the committee, functioned as its leader and played a predominant role in the negotiations. Yet, Gilburne testified that Klein "regularly reported back to the board and solicited input."[140] The record shows that the Special Committee members were involved in the sale process and deliberations. They attended numerous Special Committee meetings and calls, participated in discussions, and voiced their views on various issues. To cite one specific example, all of the Special Committee members participated in the selection and compensation of the committee's legal and financial advisors.

With respect to Volgenau, SEPTA asserts that he had "special interests separate from those of the public stockholders" and those interests "were permitted to dominate the Special Committee process."[141] There is no dispute that Volgenau's interests in the Merger were addressed by the Special Committee through the establishment of a bifurcated process in which Volgenau met with interested bidders. That decision was reasonable given that Volgenau, as the controlling stockholder, had the right to vote his shares as he wished. In that way, Volgenau's interest in preserving SRA's values and culture influenced whether a transaction might be possible. But the Plaintiff fails to cite any material evidence that Volgenau dominated the Special Committee process to achieve a transaction with Providence.

As evidence that Volgenau's influence infected the Special Committee process, the Plaintiff points to how Volgenau had unauthorized discussions with Providence after the formation of the committee.[142] The record, however, reflects that these limited, incidental contacts were harmless.[143] SEPTA further contends that Volgenau's acceptance of a promissory note in exchange for a higher bid favored Providence. While his acceptance of the note helped Providence match Veritas' bid, it was also in the best interest of the minority stockholders because, ultimately, it forced Veritas to increase its offer. Moreover, Volgenau had previously agreed to increase his rollover amount from $100 million to $150 million to allow Veritas to increase its offer.

In addition, SEPTA argues that Volgenau sought to undermine the competing bid from Veritas by sending an unflattering article about Veritas' chairman to Klein and the Special Committee. But this is not the type of behavior that one could reasonably characterize as an underhanded attempt to influence the sale process. Volgenau was merely relaying information he had obtained about Veritas to the Special Committee. Finally, the Plaintiff contends that the go-shop was, in effect, a sham because Volgenau had been assured that there were no instances of a disruptive bid emerging from a go-shop where the company being sold had a controlling stockholder.[144] This fact, however, does not establish that the go-shop was a sham or that Volgenau was disloyal or dominated the Special Committee.

In contrast to the immaterial evidence and unsupported assertions proffered by the Plaintiff, the record has ample substantive evidence that Volgenau did not dominate the Special Committee to force a transaction with Providence. It bargained hard against Providence, forcing it to increase its bid from $27.25 per share to $31.25 per share. Moreover, the Special Committee repeatedly rejected Providence's requests for exclusivity and even granted exclusivity to Veritas. It solicited a plethora of other financial and strategic sponsors to participate in the bidding process, even though Volgenau had initially expressed concerns about strategic buyers.

In conclusion, there is no dispute of material fact that the Special Committee functioned independently of Volgenau and Klein or that Klein was self-interested. Thus, the Merger was recommended by a disinterested and independent special committee. The record also establishes that the Special Committee was fully functioning and had authority to select its advisors freely. Moreover, it had the authority to recommend or not to recommend any transaction. The record also reflects that the SRA Directors were fully informed and exercised due care in approving the Merger.[145] Thus, there is no triable issue of material fact that they did not breach their duty of care in negotiating and recommending the Merger.

3. Was the Merger Approved by a Non-waivable Majority of the Minority Vote?

A fully informed, non-waivable majority of the minority vote affords minority stockholders the ability to protect themselves from an unfair deal by vetoing a transaction. When combined with an independent and disinterested special committee that functions as a bargaining agent empowered to negotiate for the highest price reasonably attainable, minority stockholders in a third-party transaction are afforded robust protections justifying review under the business judgment standard. But in order for a majority of the minority vote to be effective, stockholders must be fully and accurately informed. Although SEPTA does not dispute that the Merger was subject to a non-waivable majority of the minority vote, [146] it nonetheless contends that the minority stockholders were not fully informed.[147] In response, the Defendants argue that SEPTA has waived its disclosure claims. They further assert that the proxy was not misleading and did not omit material facts.[148]

SEPTA contends that SRA omitted material information from the proxy or made misleading disclosures therein. First, it complains about the lack of disclosure regarding Volgenau's meeting with Providence before the formation of the Special Committee, particularly, DiPentima's role in the preliminary discussions.[149] Similarly, it contends that the proxy should have disclosed that Volgenau knew that the go-shop was unlikely to produce a topping bid and that Volgenau and Sloane kept Providence apprised of SRA's bid for EIG.[150]

Second, the Plaintiff asserts that the proxy fails to discuss fully Klein's expectation and demand for additional compensation and the allegedly "contingent" aspect of Kirkland's compensation.[151] Third, SEPTA contends that the proxy should have disclosed why Veritas decided to withdraw its bid. Fourth, it contends that the proxy omitted material information relating to how the Board determined that the Merger conformed to the equal treatment provision in SRA's charter or why the Board allowed Volgenau to obtain consideration different from what the minority stockholders received. Fifth, and finally, the Plaintiff asserts that the proxy failed to disclose that CitiGroup, which advised Providence in the Merger, had been previously advising SRA's study team.[152]

Under Delaware law, directors of a Delaware corporation "are under a fiduciary duty to disclose fully and fairly all material information within the board's control when it seeks shareholder action."[153] The Plaintiff has the burden of showing that an omitted fact is material.

An omitted fact is material if there is a substantial likelihood that a reasonable shareholder would consider it important in deciding how to vote. . . . Put another way, there must be a substantial likelihood that the disclosure of the omitted fact would have been viewed by the reasonable investor as having significantly altered the total mix of information made available.[154]

Importantly, Delaware law does not require that companies "bury the shareholders in an avalanche of trivial information."[155] Nor does it require a "play-by-play description of every consideration or action taken by a Board.[156]

First, the Plaintiff claims that the proxy contained misleading statements and omitted material information regarding the exploratory meetings between Volgenau (and SRA management) and Providence. The proxy discloses an overview of those discussions but, according to SEPTA, it lacks important details. It is not obvious, and the Plaintiff has not explained, why disclosure of DiPentima's role in those meetings would have been important to a reasonable shareholder in deciding how to vote.[157] Similarly, that Volgenau was informed by Providence that the go-shop was unlikely to result in a topping bid is not a fact that would significantly alter the total mix of information made available. Finally, SRA's decision to update Providence on its bid for EIG is not particularly surprisingly or noteworthy given that Providence had expressed an interest in acquiring the Company. This type of play-by-play disclosure would not have been important to a reasonable stockholder. In addition, the Plaintiff has not shown what meetings were omitted or explained why those meetings or the contents of those meetings were material.[158] Thus, there is no dispute of material fact that the stockholders were adequately informed of the early meetings between Providence and Volgenau.

Second, should the proxy have disclosed Klein's expectation of additional compensation after the merger agreement was signed, even though he never received it? Importantly, the proxy fully and accurately discloses the compensation that Klein actually received and notes that it was not contingent upon the completion of the Merger.[159] Under these circumstances the disclosure of Klein's wishful thinking is not likely to alter significantly the total mix of information available to shareholders.[160] Moreover, SRA need not disclose why it declined Klein's request because that plainly risks inundating stockholders with unnecessary information.[161] The Plaintiff also complains about SRA's failure to disclose Kirkland's bonus, but it has failed to explain why Kirkland's discretionary compensation would have been material to a reasonable shareholder. Unlike the contingent compensation of a financial advisor, who opines on the fairness of a transaction, which shareholders rely upon in deciding how to vote, the reasons for disclosing a legal advisor's compensation are not as clear.[162] In this case, Kirkland's compensation was arguably discretionary. Accordingly, failure to disclose Kirkland's bonus did not deprive shareholders of a material fact.

Third, SEPTA asserts that the shareholders should have been informed of why Veritas, at the last minute, left the auction process. The proxy only discloses that "[Veritas] indicated that it was withdrawing its proposal and would no longer participate in the process."[163] According to Veritas, it withdrew because it believed that the Special Committee had been dragging it along by repeatedly causing it to bid higher with the mistaken belief that the process was about to be concluded.[164] One problem with the Plaintiff's complaint is that it would require SRA to disclose the subjective beliefs, opinions, and statements of a third-party involved in the bidding process.[165] To require this type of disclosure generally would risk disclosing speculative, inaccurate, and useless information. In this case, the disclosure of this information would not have been important to a reasonable stockholder. Thus, the Court is not persuaded that SRA failed to disclose a material fact or that the shareholders were not fully informed in this regard.[166]

Fourth, the Plaintiff contends that SRA should have disclosed "information regarding how the Board determined that the Merger conformed to the equal treatment requirements" in SRA's certificate.[167] This "tell me more" type of disclosure, however, is not likely to be important to a reasonable investor because the proxy discloses the material, pertinent facts: that the Board believed Volgenau was receiving compensation equivalent to that received by other stockholders and what Volgenau actually received.[168]

The Plaintiff's disclosure claim here relates to its assertion that the Board failed to adhere to the equal treatment provision. In effect, it contends that SRA should have disclosed information that would have shed light on whether the Board properly determined whether Volgenau's consideration from the Merger was equivalent to what other stockholders received. However, this type of disclosure is generally not required under Delaware law.[169]

Finally, the failure to disclose that CitiGroup had previously advised the study team and was now advising Providence did not deprive a reasonable shareholder of a material fact. The Court is not persuaded that this relationship poses a conflict of interest or would be of particular importance to a reasonable shareholder in deciding how to vote on the proposed transaction.

In sum, the Special Committee was comprised of independent and disinterested directors, and the stockholders were fully informed when they approved the Merger in a non-waivable majority of the minority vote.[170] Thus, the Court will review the Merger under the business judgment standard.

D. Did the SRA Directors Breach Their Fiduciary Duty of Loyalty?

Count I alleges that the SRA Directors breached their fiduciary duties of loyalty and care in connection with the sale of the Company to Providence. Specifically, the Complaint alleges that the SRA Directors failed to conduct a "reasonable and independent process[, ]" "obtain the best price available for the stockholders[, ]" and "disclose material information" in the proxy statement.[171] The Court has already determined that the Plaintiff's disclosure claims raise no triable issue of material fact. Thus, the Court need only address the price and process claims.

Because the SRA Directors "acted with due care, in good faith, and in the honest belief" that they were acting in the best interests of the Company, the directors' decisions are entitled to "great deference" and the Court will not "invalidate the decision[, ] . . . examine its reasonableness . . . [or] substitute [its] views for those of the board if the [directors'] decision can be 'attributed to any rational business purpose.'"[172] Thus, the "claims against the Defendants must be dismissed unless no rational person could have believed that (1) the Merger was favorable to [SRA's] minority stockholders"[173] and (2) the Board's decisions relating to the Merger were made with a business purpose.[174]

The Plaintiff asserts that the Merger price of $31.25 was inadequate and unfair. In support of that claim, SEPTA offers expert opinion that the fair value of SRA's shares as of the Merger's closing date was $41-$43 per share.[175] It also attempts to criticize and rebut the Defendants' expert's opinion and Houlihan's fairness opinion, both of which concluded that the Merger price was fair. However, none of these contentions, or the facts supporting them, raises a triable issue of material fact under the business judgment standard.

The Merger was effected at a 52.8 percent premium over the Company's unaffected stock price and was the highest price that any party was willing to pay after a six month public sale process and a thirty-day go-shop. During the sale process, approximately ten financial and strategic acquirers signed confidentiality agreements and conducted due diligence; five parties (three financial buyers and two strategic sponsors) submitted formal indications of interest, and Veritas and Providence engaged in a multi-round bidding contest. From Providence's initial indication of interest of $27.25 per share, the Special Committee negotiated with Providence and Veritas for a higher price, eventually accepting Providence's "best and final offer" of $31.25 per share. Houlihan contacted roughly 50 potential buyers during the go-shop, none of which submitted a topping bid. Moreover, Houlihan, which the Board reasonably relied upon, opined that the Merger price was fair. Finally, 81.3 percent of the total outstanding shares not owned or controlled by Volgenau voted in favor of the Merger. In light of these undisputed facts, the Court can easily conclude that there is no triable issue of material fact that a rational mind could have believed that the Merger price was fair. Thus, the Defendants are entitled to judgment on the fair price claim.

With respect to the Plaintiff's process contentions, there is no triable issue of material fact that the decisions made by the Special Committee and the Board were attributable to a rational business purpose. The Board wisely and properly decided to form a special committee when Providence emerged as a serious bidder.[176] The decision to bifurcate the sale process to facilitate Volgenau's approval of the Merger was not only rational, but practical in light of his controlling interest. For the reasons discussed above, the Plaintiff's criticisms of the Special Committee, including that Klein and Volgenau dominated or controlled it, present no triable issue of material fact. In short, the SRA Directors' conduct was clearly rational and guided by independent and qualified advisors. Even under enhanced scrutiny, there is no evidence that the SRA Directors acted unreasonably or that their actions were inconsistent with their fiduciary duties to act in the best interest of SRA's shareholders and to obtain the highest price reasonably attainable. Accordingly, the Court will not substitute its judgment for that of the SRA Directors, whose actions can plainly be attributed to a rational business purpose.

E. Did Volgenau and Sloane Breach their Fiduciary Duty of Loyalty by Engaging in Self-Dealing?

Count II alleges that Volgenau breached his fiduciary duty of loyalty by "opportunistically and secretly planning to take private the Company at a bargain price."[177] Count II further asserts that Sloane, as CEO, breached that same duty "by using his position to encourage and facilitate the Buyout."[178] The Court will first examine the allegations against Volgenau, before turning to the contentions directed to Sloane.

1. Did Volgenau Engage in Self-Dealing?

The Plaintiff's allegations against Volgenau can be summarized and broken down into four components: that Volgenau (1) would only agree to a merger with a financial buyer; (2) orchestrated a preordained deal with Providence; (3) dominated the Special Committee; and (4) received more money than minority stockholders from the Merger.

First, the Plaintiff's case against Volgenau rests in part upon his admittedly negative disposition to strategic buyers. In response, the Defendants have set forth substantial evidence that Volgenau was willing to sell his shares to a strategic sponsor once he became more acquainted with them. Indeed, Volgenau testified that his feelings toward strategic sponsors changed as it became more apparent that they respected SRA's values of honesty and service and would retain those values following a successful acquisition. Whether there is a question of material fact rests largely on whether Volgenau's transformation was real and whether Volgenau's interest dominated the sale process.

As an initial matter, Volgenau's interest in preserving SRA's "name, values, and culture" was not necessarily inconsistent with shareholder value or the duty to act in the best interest of the Company. Delaware law recognizes that a company's unique culture may increase stockholder value and may warrant protection under certain circumstances.[179]

Importantly, the Plaintiff has failed to point to any evidence showing that Volgenau or his emphasis on high ethical values dissuaded a party from bidding. In contrast, the Defendants have submitted affidavits from representatives of two strategic bidders (Boeing and CGI) that considered purchasing SRA. The Boeing representative reported that "Volgenau did not deter Boeing from submitting a bid for SRA."[180] The CGI representative testified that Volgenau was "sincerely interested in pursuing a potential strategic transaction with CGI, " and "never indicated that he was unwilling to sell to CGI or any other strategic bidder."[181] The record also reflects that Volgenau met with both strategic and financial buyers and that the Special Committee treated the bidders equally. Moreover, the evidence shows that all of the strategic sponsors dropped out for various reasons not related to Volgenau, including internal factors and a concern that an attractive return could not be achieved in light of the current market conditions in the government services industry.

Second, there is no material evidence in the record that Volgenau orchestrated a preordained deal with Providence that the Special Committee merely rubber-stamped. As set forth in greater detail above, Volgenau's early meetings with Providence did not render a deal with Providence a fait accompli. Quite the opposite, Volgenau had no control over the sale process once SRA "started down the road of exploring the possibilities of selling."[182] As the Special Committee entertained offers from other interested buyers, Volgenau agreed to "not interfere in the issue of price" and not "impose conditions on prospective bidders."[183] There is no evidence in the record that Volgenau violated this understanding. Finally, Providence withdrew temporarily from the bidding process in February 2011 because "we felt like we were a bird in the hand."[184]

Third, as discussed above, there is no evidence that Volgenau dominated the Special Committee. Just because a controlling stockholder has the ability to veto any transaction does not necessarily impair the special committee process.[185]

Fourth, the Plaintiff asserts that Volgenau engaged in self-dealing because he received greater per share consideration than the minority stockholders from the Merger. The Plaintiff's contention is based primarily on its assertion that SRA's purchase price was "unfair" and that a fair price of SRA was worth at least $41-$43 per share.[186]

Under SRA's certificate, Volgenau was entitled to receive "equal per share payments or distributions" for his Class B shares. As Volgenau explained, "[The] intention at the time . . . was for the Class B holders not to receive any preferential price for their shares."[187] There is no evidence in the record that Volgenau, or the Special Committee on his behalf, ever consciously attempted to obtain more money than the minority stockholders from the Merger. To the contrary, Volgenau's acceptance of a risky $30 million non-recourse promissory note is some evidence that Volgenau sacrificed his economic position for the minority stockholders. Most importantly, it is undisputed that the Board, including Volgenau, believed that his proceeds from the Merger were equal to or less than that received by minority stockholders. The Board rationally made that conclusion based on valuing Volgenau's differing forms of compensation to equal approximately $31.25 per share. Accordingly, Volgenau is entitled to judgment on Count II.

2. Did Sloane Disloyally Facilitate Volgenau's Alleged Self-Dealing?

The Plaintiff asserts that Sloane "facilitated Volgenau's efforts to structure an LBO with Providence"[188] by, among other things, participating in the exploratory meetings between Providence and Volgenau and keeping Providence informed of SRA's efforts to acquire EIG. Because Volgenau did not engage in self-dealing or breach his fiduciary duties of loyalty and care, Sloane could not have facilitated such conduct. Moreover, the record lacks any material evidence that Sloane breached his fiduciary duties. Accordingly, Sloane is entitled to judgment as to Count II.

F. Did the SRA Directors Breach their Duty of Loyalty by Approving a Merger that Violated SRA's Certificate of Incorporation?

Count IV of the Complaint alleges that the SRA Directors breached their duty of loyalty by approving the Merger in violation of the "equal treatment" provision in SRA's charter. That provision reads: "[u]pon the merger . . . of the Corporation . . . holders of each class of Common Stock will be entitled to receive equal per share payments or distributions . . . ."[189] The Plaintiff asserts that Volgenau violated that provision in two ways: first, by receiving different forms of consideration; and second, because he received, through his rollover interest, greater consideration than the public stockholders. The latter assertion is based primarily on the Plaintiff's contention that SRA was worth more than $31.25 per share at the time of the Merger.[190]

Contrary to SEPTA's position, the plain language of the equal treatment clause plainly permits differing forms of consideration.[191] Under SRA's charter, the word "payments" is consistently used to refer to monetary compensation, [192]while the term "distributions" typically is associated with the distribution of securities. The common usage of these terms may encompass other forms of consideration.[193] The use of the word "or" shows that either form of consideration is acceptable. Moreover, the word "equal" does not require identical forms of consideration.[194]

This reading is also consistent with the underlying purpose of the equal treatment clause.[195] The creation of class B stock for Volgenau was intended both to preclude him from receiving a premium for his shares and to protect against a hostile takeover; there is no evidence in the charter or the record that it was intended to prevent him from receiving a different form of consideration. Finally, as the Defendants persuasively argue, this interpretation comports with the public policy of facilitating efficient transactions.[196]

The second issue is a closer question. In their depositions, the SRA Directors could not recall if the Board ever specifically discussed whether Volgenau's rollover interest was equal on a per share basis to the consideration received by the public stockholders.[197] The Plaintiff seizes upon this fact to assert that the SRA Directors acted disloyally by consciously disregarding their duty or by knowingly violating positive law.[198]

However, at the time of the Merger, the Board understood that Volgenau was receiving equal or less consideration than the minority shareholders.[199] The merger agreement was structured such that Volgenau's rollover stock (4.8 million shares) was equivalent to $150 million based on the $31.25 per share purchase price that all stockholders received.[200] As reflected in the proxy, the Board understood that Volgenau's interest in the new entity would not exceed $150 million. Houlihan had conducted a contemporaneous valuation that confirmed that $31.25 was a fair price for each share of SRA stock. When Providence proposed the $30 million non-recourse note to Volgenau, the Special Committee specifically determined that Volgenau's economic benefit from the note would be capped at $30 million.[201] Thus, despite not formally addressing the matter, the evidence shows that the Board believed that Volgenau received equal or less consideration than the minority stockholders.

While the actual value of an SRA share at the time of the Merger may very well be a dispute of material fact, the Plaintiff is seeking precision in a practice (i.e., the valuing of enterprises) that defies exactness. Consistent with this reality and the deference typically afforded directors, the question is whether the Board's business judgment was both rational and made in good faith.

There is no genuine issue of material fact that the Board acted rationally when it assumed that Volgenau's rollover interest was equal to or less than $150 million.[202] Houlihan had opined that the Merger price was fair and, after a robust sale process, no higher bid had emerged. The Plaintiff has not pointed to any evidence showing that the SRA Directors believed that Volgenau's rollover interest exceeded that amount. In fact, because the note had considerable risk and no upside, the Board generally believed that Volgenau was receiving less consideration. Accordingly, there is no dispute of material fact that the SRA Directors did not consciously disregard a known duty or intentionally violate the charter. The Defendants are therefore entitled to judgment on Count IV.

G. The Duty of Care and SRA's Exculpatory Provision

Even if the SRA's Directors had not satisfied their duty of care, the presence of an exculpatory provision authorized by 8 Del. C. § 102(b)(7) in SRA's charter exculpates them from money damages arising from a breach of their duty of care because they acted loyally and in good faith. Accordingly, the SRA Directors are entitled to summary judgment on the Plaintiff's duty of care claims on that basis as well.[203]

H. The Aiding and Abetting Claim

The Plaintiff asserts in Count III that Providence aided and abetted the SRA Directors' breach of their fiduciary duties. An aiding and abetting claim turns on "proof of scienter of the alleged abettor."[204] The Plaintiff bears the burden to show that: (1) the SRA Directors owed a fiduciary duty to SEPTA; (2) the SRA Directors breached that duty; (3) Providence "knowingly participated in the breach;" and (4) the Plaintiff suffered damages "from the concerted action of the [SRA Directors] and [Providence]."[205] Because the SRA Directors did not breach their fiduciary duties, Providence is entitled to judgment on the Plaintiff's aiding and abetting claim.

Even if the record contained a material fact supporting a breach of fiduciary duty by the SRA Directors, the record does not contain facts evidencing that Providence knowingly participated in such a breach. The following, undisputed evidence collectively demonstrates that Providence was an arms-length bidder.[206]

• There no evidence in the record that Providence and SRA, during their initial meetings, hatched a plan for Providence to "opportunistically" acquire SRA at a bargain price.[207]
• Instead of pursuing a possible transaction with Providence, Volgenau and the Board approved the formation of the strategic study team to assess the strategic options available to SRA.[208]
• SRA pursued the acquisition of Lockheed Martin's EIG, notwithstanding the fact that Providence indicated that it would not pursue an acquisition of SRA if it acquired EIG.[209]
• From July to mid-October 2010, discussions between Providence and SRA ceased as SRA attempted to buy EIG.
• The Special Committee refused to commence negotiations with Providence at their initial indication of interest of $27.25 and $28.50 per share.[210]
• The Special Committee's initial strategy was to extract from Providence a high bid that it could use as a floor to commence an auction process.[211]
• The Special Committee repeatedly declined requests for exclusivity, causing Providence to withdraw from the auction for a short period, and repeatedly forced Providence to increase its bid.[212]
• SRA entered into exclusive negotiations with Veritas on the last day before the submission of the final bids.[213]

The Plaintiff has not refuted this evidence or otherwise shown that there is a dispute of material fact.[214] Providence, therefore, is entitled to judgment on Count III.

IV. CONCLUSION

As does MFW, this case serves as an example of how the proper utilization of certain procedural devices can avoid judicial review under the entire fairness standard and, perhaps in most instances, the burdens of trial. Providence's acquisition of SRA was recommended by a fully functioning, independent special committee that was empowered to negotiate on behalf of the minority stockholders. It had the ability to hire independent advisors and not recommend a transaction. Fully informed shareholders voted overwhelmingly in favor of the Merger in a non-waivable majority of the minority vote.

SEPTA's challenge to the Merger falls short because there is no triable issue of material fact as to whether the SRA Directors' breached their fiduciary duties. The Board's decisions were rational (and reasonable) and made in good faith. Accordingly, the Defendants are entitled to judgment on all counts.

An implementing order will be entered.


Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.